期刊文献+

血浆置换联合去甲肾上腺素治疗重型肝炎合并Ⅱ型肝肾综合征的临床疗效分析 被引量:6

The study on plasma exchange combined with noradrenalin in the treatment of severe hepatitis with type Ⅱ hepatorenal syndrome
下载PDF
导出
摘要 目的探讨血浆置换联合去甲肾上腺素对重型肝炎合并Ⅱ型肝肾综合征(hepatorenal syndrome,HRS)的疗效。方法 67例重型肝炎合并Ⅱ型HRS患者分为3组,均给予内科综合治疗;A组(n=19)为对照组,B组(n=23)给予去甲肾上腺素持续静脉泵入,C组(n=25)采用血浆置换联合去甲肾上腺素治疗。观察各组肝肾功能、终末期肝病模型评分(MELD评分)、尿量以及住院病死率。结果 A、B、C3组治疗后总胆红素分别为(254.50±143.41)、(129.65±60.28)、(97.39±39.53)μmol/L;肌酐分别为(153.07±81.00)、(148.00±82.36)、(81.28±12.98)μmol/L;MELD评分分别为27.91±6.55、25.98±8.06、19.26±2.22;尿量分别为(678.42±309.16)、(819.57±66.90)、(1611.20±225.71)ml。C组治疗后肌酐、MELD评分以及尿量与A、B组治疗后比较均有显著性差异(P<0.05),C组治疗后总胆红素与A组治疗后比较有显著性差异(P<0.05)。C组治疗前后比较,各指标均有显著性差异(P<0.05)。3组住院病死率分别为68.4%、43.5%和28.0%,3组比较有显著性差异(掊2=7.157,P<0.05)。结论血浆置换联合去甲肾上腺素是治疗重型肝炎合并Ⅱ型HRS的有效方法。 Objective To evaluate the effect of plasma exchange combined with noradrenalin in the treatment of severe hepatitis with type Ⅱ hepatorenal syndrome.Methods Sixty-seven patients with severe hepatitis and type II hepatorenal syndrome were included and were divided into the control group(group A),plasma exchange group(group B) and plasma exchange combined with noradrenalin treatment group(group C).The etiopathogenisis,liver function,renal function,the MELD score,urinary volume and mortality were analyzed.Results After treatment,the total bilirubin level of group A,B and C was(254.50±143.41),(129.65±60.28),(97.39±39.53)μmol/L,respectively.The creatinine level of group A,B and C was(153.07±81.00),(148.00±82.36),(81.28±12.98) μmol/L,respectively.The MELD score of group A,B and C was 27.91±6.55,25.98±8.06,19.26±2.22,respectively and the urinary volume of group A,B and C was(678.42±309.16),(819.57±466.90),(1611.20±225.71)ml,respectively.There were significant differences of all the above parameters between group A and C(P 0.05).There were significant differences between group C and B in creatinine level,the MELD score and the urinary volume(P 0.05).The differences in case mortality between group A,B and C(68.4% vs.43.5% vs.28.0%),were significant(χ2=7.157,P 0.05).Conclusion Plasma exchange combined with noradrenalin is effective in treating severe hepatitis with type II hepatorenal syndrome.
出处 《北京医学》 CAS 2011年第9期713-716,共4页 Beijing Medical Journal
关键词 重型肝炎 肝肾综合征 血浆置换 去甲肾上腺素 Severe hepatitis Hepatorenal syndrome(HRS) Plasma exchange Noradrenalin
  • 相关文献

参考文献9

二级参考文献19

  • 1薛恩生,林礼务,叶真,高上达,何以敉.肝内动脉多普勒超声的检测及其临床意义[J].中国超声医学杂志,1993,9(4):233-235. 被引量:17
  • 2刘强,彭莉,杜艺,李宓,贾宁,邹和群.新型人工肝单纯白蛋白透析治疗肝衰竭的临床研究[J].中国危重病急救医学,2005,17(10):599-602. 被引量:18
  • 3季大玺,龚德华.白蛋白透析的临床应用[J].肾脏病与透析肾移植杂志,2006,15(1):77-81. 被引量:1
  • 4Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club [ J]. Hepatology, 1996, 23 (1) : 164-176. 被引量:1
  • 5Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites [J]. Gastroenterology, 1993, 105(1):229-236. 被引量:1
  • 6Gonwa TA, Klintmalm GB, Levy M, et al. Impact of pretransplant renal funclion on survival after liver transplantation [ J]. Transplantation, 1995, 59(3) : 361-365. 被引量:1
  • 7Gulberg V, Bilzer M, Gerbes AL. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine [ J ]. Hepatology, 1999, 30(4) : 870-875. 被引量:1
  • 8Duvoux C, Zanditenas D, Hezode C, et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study [ J ]. Hepatology, 2002, 36 (2) : 374-380. 被引量:1
  • 9Alessandria C, Ottobrelli A, Debernardi-Venon W, et al. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study [ J ]. J Hepatol, 2007, 47 (4) : 499 -505. 被引量:1
  • 10Kreymann B. Dying patients need a good relationship with their doctor [J]. BMJ, 1999, 319 (7212): 785. 被引量:1

共引文献14061

同被引文献67

引证文献6

二级引证文献1403

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部